Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Neoadjuvant Therapy × Clear all

Phase

Status

Sponsor Class

NIH 2 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 70 Colorectal Neoplasms 34 Rectal Neoplasms 33 Esophageal Neoplasms 25 Esophageal Squamous Cell Carcinoma 23 Carcinoma, Non-Small-Cell Lung 23 Pancreatic Neoplasms 16 Neoplasms 15 Stomach Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 14 Adenocarcinoma Of Esophagus 14 Lung Neoplasms 11 Colonic Neoplasms 11 Carcinoma, Hepatocellular 11 Sarcoma 10 Prostatic Neoplasms 10 Ovarian Neoplasms 10 Head and Neck Neoplasms 10 Neoplasm Metastasis 9 Urinary Bladder Neoplasms 8 Uterine Cervical Neoplasms 7 Osteosarcoma 6 Recurrence 5 Multiple Myeloma 5 Fallopian Tube Neoplasms 5 Carcinoma, Intraductal, Noninfiltrating 5 Breast Carcinoma In Situ 5 Peritoneal Neoplasms 4 Nasopharyngeal Carcinoma 4 Locally Advanced Rectal Cancer 4

Interventions

Temozolomide 108 Magnetic Resonance Spectroscopy 51 Bevacizumab 51 Radiotherapy 43 Irinotecan 27 Blood Specimen Collection 18 Surgical Procedures, Operative 16 Radiation 15 Aminolevulinic Acid 15 Carboplatin 13 Nivolumab 12 fluorodopa F 18 11 Radiotherapy, Intensity-Modulated 11 Carmustine 11 Radiosurgery 10 Magnetic Resonance Imaging 10 pembrolizumab 9 Topotecan 9 Specimen Handling 9 Everolimus 9 Erlotinib Hydrochloride 9 Biopsy 9 poly ICLC 8 Surveys and Questionnaires 8 Standard of Care 8 Etoposide 8 Drug Therapy 8 Filgrastim 7 Cyclophosphamide 7 ribociclib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04209790 2025-11-10

NeoGlio

Geisinger Clinic

Phase 2 Terminated

2 enrolled 7 charts

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡